Drugs / TTRNA-DCs
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01326104 | Sep 2010 → Mar 2020 | medulloblastoma, primitive neuroectodermal tumor | University of Florida | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TTRNA-DCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01326104 ↗ |
| Modality | Vaccine | “TTRNA-loaded dendritic cell vaccine” NCT01326104 ↗ |
| Route | Other | “by intradermal injection” NCT01326104 ↗ |